M. Rapp et al. / Journal of Fluorine Chemistry 132 (2011) 1232–1240
1237
3.95 (1H, dd, J5 -5 = 10.2 Hz, J5 -4 = 4.5 Hz, H-50), 4.20 (1H, dd, J4-
(10% EtOAc/hexane) to give 5b (62 mg, 52%) as slightly yellow oil.
Compound 5b had: [ ] D 25 +48 (c 0.2, CHCl3); IR (KBr) 3368, 3063,
0
0
0
5 = 6.9 Hz, J4-5 = 4.5 Hz, H-4), 4.57 (1H, d, J = 12.0 Hz, Bn), 4.64 (1H,
a
n
d, J2-1 = 3.8 Hz, H-2), 4.68 (1H, d, J = 12.0 Hz, Bn), 5.94 (1H, d, J1-
3031, 2989, 2933, 2869, 1605, 1498, 1450, 1383, 1375, 1257, 1216,
1102, 1078, 1023, 873, 763, 697 cmꢀ1; 1H NMR:
d 1.40 (3H, s, i-Pr),
2 = 3.7 Hz, H-1), 7.26–7.42 (10H, m, Ph); 13C NMR:
d
26.6, 26.7, 69.5,
0
73.7, 75.6, 80.7, 83.7, 84.9, 88.0, 104.3, 113.4, 121.6, 127.7, 127.8,
128.3, 128.9, 131.8, 137.7; MS m/z (rel. int.) 91 [C7H7]+ (100), 365
[M-Me]+ (5), 380 [M]+ (3); Anal. Calcd for C23H24O5 ꢂ 0.25 H2O: C,
71.76; H, 6.42. Found: C, 71.79; H, 6.41.
1.65 (3H, s, i-Pr), 3.09 (1H, dd, J5-5 = 10.8 Hz, J5-4 = 7.9 Hz, H-5), 3.28
(1H, s, OH), 3.34 (1H, dd, J5 -5 = 10.8 Hz, J5 -4 = 3.1 Hz, H-50), 4.29 (1H,
dd, J4-5 = 7.8 Hz, J4-5 = 3.1 Hz, H-4), 4.32 (1H, d, J = 11.9 Hz, Bn), 4.40
(1H, d, J2-1 = 4.0 Hz, H-2), 4.46 (1H, d, J = 11.9 Hz, Bn), 6.12 (1H, d, J1-
2 = 4.0 Hz, H-1), 7.27–7.42 (10H, m, Ph); 13C NMR:
d 26.5, 26.6, 69.2,
0
0
0
3.4. Preparation of 1,2;5,6-di-O-isopropylidene-C-3-(E)-styryl-
a
-
D
-
73.3, 80.0, 83.3, 84.4, 92.9, 105.1, 112.8, 124.3, 125.0, 126.6, 127.5,
127.6, 127.7, 128.2, 137.9, 138.7; MS m/z (rel. int.) 91 [C7H7]+ (100),
341 [MꢀMe]+ (6), 356 [M]+ (5); HRMS (EI) Calcd for C21H24O5 [M]+:
356.16238; Found: 356.16451.
allofuranose 4a
To the solution of 3a (114 mg, 0.32 mmol) in Et2O (7 mL), a
suspension of LiAlH4 (16 mg, 0.41 mmol) in Et2O (8 mL) at 0 8C was
added. The reaction mixture was stirred at room temperature for
3.7. Preparation of 3-deoxy-3-fluoro-1,2;5,6-di-O-isopropylidene-C-
3.5 h and then was quenched by addition of water (24
m
L), 10%
3(R)-vinyl-a-D-glucofuranose 6a and 3-deoxy-C-3-(2-
aqueous solution of KOH (48 L) and water (72 L). The mixture
m
m
fluoroethylidene)-1,2;5,6-di-O-isopropylidene-a-D-ribohexofuranose
was filtered and the precipitate was washed with Et2O. The
combined organic layers were dried (MgSO4) and the product was
column chromatographed (20% EtOAc/hexane) to give alcohol 4a
7a
PFPDEA (156 mg, 0.84 mmol) in anhydrous CH2Cl2 (2 mL) was
added dropwise to the solution of 2a (120 mg, 0.42 mmol) in
CH2Cl2 (4 mL), and the mixture was stirred for 18 h at room
temperature. Then solvent was evaporated to give crude mixture of
6a/7a (ꢃ60%, 1:1; 1H NMR and 19F NMR). The reaction mixture was
partitioned (H2O//CH2Cl2) and the separated inorganic layer was
extracted (CH2Cl2), dried (MgSO4), evaporated and carefully
column chromatographed (0 ! 30% EtOAc/hexane) to give 6a
(38 mg, 31%) and 7a (41 mg, 34%) as slightly yellow oils.
Compound 6a [less polar than 7a and 2a on TLC (EtOAc/hexane,
(110 mg, 96%) as an oil. Compound 4a had [
CHCl3); IR (KBr) 3461, 3085, 3060, 3028, 2997, 2986, 2972, 2945,
2936, 2895, 2887, 1382, 1372, 1212, 1166, 1156, 973, 878, 855,
750, 691 cmꢀ1; 1H NMR:
1.29 (3H, s, i-Pr), 1.37 (3H, s, i-Pr), 1.44
a] D 25 –168 (c 0.3,
n
d
(3H, s, i-Pr), 1.65 (3H, s, i-Pr), 2.95 (1H, s, OH), 3.91–4.06 (3H, m, H-
60, H-6, H-5), 4.17 (1H, q, J4-5/6/6 = 6.1 Hz, H-4), 4.36 (1H, d, J2-
0
1 = 3.6 Hz, H-2), 5.87 (1H, d, J1-2 = 3.6 Hz, H-1), 6.14 (1H, d, Ja-
b=16.1 Hz, H-a), 6.92 (1H, d, Jb-a=16.1 Hz, H-b), 7.22–7.49 (5H, m,
Ph); 13C NMR:
d 25.3, 26.4, 26.6, 26.7, 66.8, 73.9, 80.4, 81.6, 83.8,
103.8, 109.4, 113.2, 125.7, 126.6, 127.9, 128.7, 131.3, 136.2; MS m/z
(rel. int.) 91 [C7H7]+(25), 347 [M-Me]+ (8), 362 [M]+ (1); HRMS (EI)
Calcd for C19H23O6 [MꢀMe]+: 347.14948; Found: 347.14768.J4-5/
6/60 = 6.1 Hz,
2:8)] had [
2899, 1456, 1417, 1384, 1375, 1252, 1218, 1165, 1080, 1012,
875 cmꢀ1; 1H NMR:
1.33 (3H, s, i-Pr), 1.34 (3H, s, i-Pr), 1.42 (3H, s,
a] D 25 +778 (c 0.3, CHCl3); IR (KBr/neat) n 2989, 2937,
d
0
0
0
i-Pr), 1.54 (3H, s, i-Pr), 3.99 (1H, ddd, J6 -6 = 8.7 Hz, J6 -5 = 6.4 Hz, J6 -
b = 1.9 Hz, H-60), 4.06 (1H, dd, J6-6 = 8.9 Hz, J6-5 = 5.7 Hz, H-60), 4.24
0
0
3.5. Preparation of 5-O-benzyl-1,2-O-isopropylidene-C-3-(E)-styryl-
(1H, q, J5-4/6/6 = 5.5 Hz, H-5), 4.25 (1H, dd, J4-F = 31.5 Hz, J4-
a
-D
-ribofuranose 4b
5 = 5.1 Hz, H-4), 4.43 (1H, dd, J2-F = 11.4 Hz, J2-1 = 3.7 Hz, H-2),
0
0
5.41 (1H, ddd, Jb-a = 11.3 Hz, Jb-6 = 2.1 Hz, Jb-b = 1.2 Hz, H-b), 5.53
0
0
Analogous treatment of 3b (122 mg, 0.32 mmol) in Et2O (7 mL),
(1H, dd, Jb -a = 17.5 Hz, Jb -b = 1.2 Hz, H-b0), 5.94 (1H, d, J1-2 = 3.7 Hz,
0
with a suspension of LiAlH4 (16 mg, 0.41 mmol) in Et2O (8 mL,
3.5 h) gave after isolation compound 4b (98 mg, 80%) as a white
H-1), 5.99 (1H, ddd, Ja-F = 21.6 Hz, Ja-b = 17.5 Hz, Ja-b = 11.3 Hz, H-
a); 13C NMR:
d 25.4 (i-Pr), 26.5 (i-Pr), 26.9 (i-Pr), 29.7 (i-Pr), 65.8 (d,
solid. Compound 4b had [
3441, 3028, 2993, 2934, 2904, 2868, 1600, 1577, 1495, 1386, 1166,
1146, 1099, 999, 880, 753, 696 cmꢀ1; 1H NMR:
1.63 (3H, s, i-Pr), 2.93 (1H, s, OH), 3.55 (1H, dd, J5-5 = 10.7 Hz, J5-
4 = 7.2 Hz, H-5), 3.64 (1H, dd, J5 -5 = 10.7 Hz, J5 -4 = 3.5 Hz, H-50),
4.17 (1H, dd, J4-5 = 7.2 Hz, J4-5 = 3.5 Hz, H-4), 4.30 (1H, d, J2-
1 = 3.8 Hz, H-2), 4.46 (1H, d, J = 12.1 Hz, Bn), 4.59 (1H, d, J = 12.1 Hz,
Bn), 5.94 (1H, d, J1-2 = 3.8 Hz, H-1), 6.09 (1H, d, Ja-b = 16.0 Hz, H-a),
6.87 (1H, d, Jb-a = 16.0 Hz, H-b), 7.24–7.41 (10H, m, Ph); 13C NMR:
a
] D 25 –178 (c 0.5, CHCl3); IR (KBr)
n
J = 5.1 Hz, C-5), 72.4 (d, J = 4.7 Hz, C-6), 81.4 (d, J = 19.5 Hz, C-4),
85.5 (d, J = 37.7 Hz, C-2), 101.2 (d, J = 184.1 Hz, C-3), 104.8 (C-1),
109.0 (i-Pr), 113.0 (i-Pr), 117.9 (d, J = 12.0 Hz, C-b), 130.5 (d,
d
1.37 (3H, s, i-Pr),
J = 19.5 Hz, C-a); 19F NMR:
d
ꢀ181.3 (ddd, JF-4 = 31.5 Hz, JF-
0
a = 21.6 Hz, JF-2 = 11.5 Hz, 1F); MS (APCI) m/z 289.2 [M+ H]+; HRMS
(EI) Calcd for C13H18O5F [MꢀMe]+: 273.11383; Found: 273.11422.
Compound 7a [more polar than 6a and less polar than 2a on TLC
0
0
0
(EtOAc/hexane, 2:8)] had [
n
a
] D 25 +528 (c 0.2, CHCl3); IR (KBr/neat)
d
3093, 2990, 2940, 2901, 1457, 1417, 927, 875, 845, 802 cmꢀ1; 1H
26.5, 26.6, 69.8, 73.5, 79.8, 81.8, 83.4, 103.9, 112.9, 124.9, 126.5,
127.6, 127.7, 127.9, 128.3, 128.6, 130.6, 136.3, 137.8; MS m/z (rel.
int.) 91 [C7H7]+ (100), 367 [MꢀMe]+(2); Anal. Calcd for C23H26O5: C,
72.23; H, 6.85. Found: C, 72.10; H, 7.05.
NMR: d 1.36 (3H, s, i-Pr), 1.38 (3H, s, i-Pr), 1.44 (3H, s, i-Pr), 1.48
(3H, s, i-Pr), 3.95 (1H, dd, J6 -6 = 7.3 Hz, J6 -5 = 4.7 Hz, H-60), 4.00–
4.06 (1H, m, H-6), 4.06–4.10 (1H, m, H-5), 4.64 (1H, tdd, J4-
F = 5.0 Hz, J4-5 = 3.4 Hz, J4-6/a = 1.9 Hz, H-4), 5.03 (1H, dddd, Jb-
0
0
0
F = 46.5 Hz, Jb-a = 5.4 Hz, Jb-b = 1.9 Hz, Jb-2 = 0.5 Hz, H-b), 5.14 (1H,
0
3.6. Preparation of 5-O-benzyl-1,2-O-isopropylidene-C-3-phenyl-
-ribofuranose 5b
a-
tdd, J2-1 = 4.0 Hz, J2-F = 2.5 Hz, J2-b = 0.5 Hz, H-2), 5.19 (1H, ddd, Jb -
0
0
D
F = 47.2 Hz, Jb -b = 1.4 Hz, Jb -a = 7.5 Hz, H-b0), 5.85 (1H, d, J1-
2 = 4.3 Hz, H-1), 6.14 (1H, dddt, Ja-F = 12.9 Hz, Ja-b = 5.5 Hz, Ja-
b0
To the magnetically stirred suspension of magnesium turnings
(24 mg, 1.0 mmol) and a few crystals of I2 in dry THF (1.5 mL) in
L, 104 mg, 0.66 mmol)
was added. The reaction mixture was refluxed for 2 h. Next, the
solution of ketone 1b (93 mg, 0.33 mmol) in anhydrous THF (1 mL)
at 0 8C was added and the reaction was stirred at room temperature
overnight. Then, the resulting mixture was partitioned (1 N HCl/
H2O//Et2O). The combined extracts were washed with water, brine,
dried (MgSO4), evaporated and carefully column chromatographed
= 7.2 Hz, Ja-4/5 = 1.9 Hz, H-a); 13C NMR:
d 25.4 (i-Pr), 26.6 (i-Pr),
27.2 (i-Pr), 27.3 (i-Pr), 60.4 (C-6), 66.9 (C-5), 78.4 (C-4), 79.9 (d,
J = 161.0 Hz, C-b), 79.9 (C-2), 104.9 (C-1), 109.9 (i-Pr), 112.7 (i-Pr),
123.2 (d, J = 19.7 Hz, C-a), 142.7 (d, J = 10.7 Hz, C-3); 19F NMR:
d
Carius tube at ꢀ20 8C bromobenzene (69
m
0
ꢀ214.6 (tddd, JF-b/b = 46.7 Hz, JF-a = 13.2 Hz, JF-4 = 5.4 Hz, JF-
2 = 2.5 Hz, 1F); MS (APCI) m/z 289.2 [M+ H]+; HRMS (EI) Calcd
for C13H18O5F [MꢀMe]+: 273.11383; Found: 273.11403.
Note 1: Analogous treatment of 2a in CH2Cl2 with DAST (1.5 eq,
1 h, ꢀ78 8C; 1 h, RT) gave 6a/7a (1.6:1) with 26%/16% yields.